Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Profs. Wytske Fokkens and Joaquim Mullol.
February 27 is Anosmia Awareness Day. Anosmia, which refers to complete loss of smell, and hyposmia, which refers to a decreased sense of smell, are symptoms in up to 90% of people with uncontrolled CRSwNP and are among the symptoms most associated with decreased quality of life, according to those who experience them.1,2 Even with treatment, altered sense of smell is one of the most recalcitrant symptoms of CRSwNP.2
Learn more about altered sense of smell in CRSwNP and type 2 inflammation, which is present in 87% of patients with CRSwNP and is known to play a role in disease pathology, by exploring the resources available at ADVENTprogram.com.3
1. Fokkens WJ, et al. Rhinology. 2020;Suppl. 29:1-464. 2. Mullol J, et al. J Allergy Clin Immunol Pract. 2022;10(4):1086-1095.e5. 3. Stevens WW, et al. J Allergy Clin Immunol Pract. 2019;7(8):2812-2820.e3.